Use of In Vitro Susceptibility and Pathogen Prevalence Data to Model the Expected Clinical Success Rates of Tigecycline and Other Commonly Used Antimicrobials for Empiric Treatment of Complicated Skin and Skin Structure Infections (cSSSI) in France, Germany and Italy
Use of In Vitro Susceptibility and Pathogen Prevalence Data to Model the Expected Clinical Success Rates of Tigecycline and Other Commonly Used Antimicrobials for Empiric Treatment of Complicated Skin and Skin Structure Infections (cSSSI) in France, Germany and Italy, Lead author: Sader HS, presented at 12th annual International Congress on Infectious Diseases (ICID), June 15 – 18, 2006, Lisbon, Portugal
